Hvorom alting er, saa undersoegte jeg Alzheimers/Parkinson-landskabet en lille smule af ren nysgerrighed og vil blot dele et par link, som jeg stoedte paa undervejs.

2019 - Alzheimer's disease drug development pipeline: 2019
https://www.ncbi.nlm.nih.gov/pubmed/31334330

2008 - Alzheimer's Disease Is Type 3 Diabetes
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769828/

2020 - Could an NLRP3 inhibitor be the one drug to conquer common diseases?
https://cen.acs.org/pharmaceuticals/drug-discovery/Could-an-NLRP3-inhibitor-be-the-one-drug-to-conquer-common-diseases/98/i7

Biogen (Aducanumab):
https://www.biogen.com/en_us/pipeline.html
"Buffett's a believer: Berkshire bets $192M on Biogen ahead of key Alzheimer's filing"
https://www.fiercepharma.com/pharma/a-192m-moat-buffett-s-berkshire-builds-stake-biogen-ahead-key-alzheimer-s-drug-filing

Agenebio:
https://www.agenebio.com/pipeline/agb101-for-amnestic-mild-cognitive-impairment-amci/
"AGB101 is in development to treat mild cognitive impairment due to Alzheimer's disease (MCI due to AD) and to delay progression to Alzheimer's dementia."

Biohaven (BHV4157-203 / Troriluzole):
https://www.biohavenpharma.com/science-pipeline/our-pipeline

Cortexyme (COR388):
https://www.cortexyme.com/?page_id=6022

Anavex (Anavex 2-73):
https://www.anavex.com/

IFM Therapeutics:
https://www.ifmthera.com/pipeline/
2019-04-01
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre
https://www.novartis.com/news/media-releases/novartis-adds-clinical-and-preclinical-anti-inflammatory-programs-portfolio-acquisition-ifm-tre

Inflazome:
http://inflazome.com/pipeline.html

Nodthera:
https://www.nodthera.com/why-nrlp3/

Lundbeck:
https://www.lundbeck.com/global/brain-disorders/pipeline